SUPERNUS PHARMACEUTICALS
SUPN·868459108·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
SUPN (SUPERNUS PHARMACEUTICALS) is held by 159 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($454.7M), MILLENNIUM MANAGEMENT LLC ($171.4M), VANGUARD PORTFOLIO MANAGEMENT LLC ($167.4M). Net institutional sentiment: Mixed. In Q1 2026, 1 member of Congress and 94 funds bought SUPN.
159
Holders
(14 Elite)
$2.5B
Total Value
55% (171)
Consensus
94 buying - 77 selling
13F: Insider & Congress:
Who's Trading
InsiderBPBhatt Padmanabh P.Sell $339KMar 18, 2026
InsiderBPBhatt Padmanabh P.Sell $21KMar 18, 2026
InsiderBPBhatt Padmanabh P.Sell $1.4MMar 17, 2026
InsiderBPBhatt Padmanabh P.Sell $1.1MMar 17, 2026
Top Holders
Showing 1-20 of 177
1 / 9
Continue exploring
Other Healthcare stocks held by institutions
413 holders · $666.6B
413 holders · $186.3B
394 holders · $391.3B
392 holders · $97B
391 holders · $123.5B
391 holders · $147B
389 holders · $76.8B
385 holders · $208.9B
381 holders · $254.9B
380 holders · $129.1B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer